• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Modifiable practices associated with sudden death among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study.可改变的实践与血液透析患者在透析结果和实践模式研究中的突然死亡相关。
Clin J Am Soc Nephrol. 2012 May;7(5):765-74. doi: 10.2215/CJN.08850811. Epub 2012 Mar 8.
2
Low Potassium Dialysate as a Protective Factor of Sudden Cardiac Death in Hemodialysis Patients with Hyperkalemia.低钾透析液作为高钾血症血液透析患者心脏性猝死的保护因素
PLoS One. 2015 Oct 6;10(10):e0139886. doi: 10.1371/journal.pone.0139886. eCollection 2015.
3
Dialysate Potassium, Serum Potassium, Mortality, and Arrhythmia Events in Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS).血液透析中透析液钾、血清钾、死亡率及心律失常事件:透析结局与实践模式研究(DOPPS)结果
Am J Kidney Dis. 2017 Feb;69(2):266-277. doi: 10.1053/j.ajkd.2016.09.015. Epub 2016 Nov 17.
4
We Use Dialysate Potassium Levels That Are Too Low in Hemodialysis.我们在血液透析中使用的透析液钾水平过低。
Semin Dial. 2016 Jul;29(4):300-2. doi: 10.1111/sdi.12495. Epub 2016 Apr 8.
5
Postdialysis Hypokalemia and All-Cause Mortality in Patients Undergoing Maintenance Hemodialysis.维持性血液透析患者透析后低钾血症与全因死亡率。
Clin J Am Soc Nephrol. 2019 Jun 7;14(6):873-881. doi: 10.2215/CJN.07950718. Epub 2019 May 2.
6
Dialysate and serum potassium in hemodialysis.血液透析中的透析液和血清钾。
Am J Kidney Dis. 2015 Jul;66(1):125-32. doi: 10.1053/j.ajkd.2015.02.322. Epub 2015 Mar 28.
7
Association of dialysate bicarbonate concentration with mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS).透析液碳酸氢盐浓度与 Dialysis Outcomes and Practice Patterns Study (DOPPS) 死亡率的关系。
Am J Kidney Dis. 2013 Oct;62(4):738-46. doi: 10.1053/j.ajkd.2013.03.035. Epub 2013 May 24.
8
Primary outcomes of the Monitoring in Dialysis Study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle.监测透析研究的主要结果表明,临床上显著的心律失常在血液透析患者中很常见,与透析周期有关。
Kidney Int. 2018 Apr;93(4):941-951. doi: 10.1016/j.kint.2017.11.019. Epub 2018 Feb 12.
9
Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS).维持性血液透析患者透析前血清钠水平、透析液钠与死亡率:透析结局和实践模式研究(DOPPS)。
Am J Kidney Dis. 2012 Feb;59(2):238-48. doi: 10.1053/j.ajkd.2011.07.013. Epub 2011 Sep 23.
10
Dialysis Prescription and Sudden Death.透析处方与猝死。
Semin Nephrol. 2018 Nov;38(6):570-581. doi: 10.1016/j.semnephrol.2018.08.003.

引用本文的文献

1
Relationship Between Timing of Hemodialysis and Procedure-Related Complications Following Endoscopy in Patients with End-Stage Renal Disease.终末期肾病患者内镜检查后血液透析时机与手术相关并发症的关系
Dig Dis Sci. 2025 Jun 19. doi: 10.1007/s10620-025-09155-z.
2
Twice against thrice-weekly hemodialysis (TATH): a multicenter nonrandomized trial.每周两次对比每周三次血液透析(TATH):一项多中心非随机试验。
BMC Nephrol. 2025 Apr 5;26(1):176. doi: 10.1186/s12882-025-04105-3.
3
The association between systolic and diastolic dysfunction and autonomic nervous system function in children receiving chronic hemodialysis.接受长期血液透析的儿童的收缩和舒张功能障碍与自主神经系统功能之间的关联。
Pediatr Nephrol. 2025 Jan 28. doi: 10.1007/s00467-024-06577-1.
4
Sudden Cardiac Arrest Associated with Hemodialysis: A Community-Based Study.与血液透析相关的心脏骤停:一项基于社区的研究。
Kidney360. 2025 May 1;6(5):805-813. doi: 10.34067/KID.0000000705. Epub 2025 Jan 17.
5
Type of arrhythmias and the risk of sudden cardiac death in dialysis patients: a systematic review and meta-analysis.透析患者心律失常类型与心源性猝死风险:一项系统评价和荟萃分析
Egypt Heart J. 2025 Jan 13;77(1):11. doi: 10.1186/s43044-025-00606-6.
6
The Controversies of Coronary Artery Disease in End-Stage Kidney Disease Patients: A Narrative Review.终末期肾病患者冠状动脉疾病的争议:一项叙述性综述
Rev Cardiovasc Med. 2023 Jun 25;24(6):181. doi: 10.31083/j.rcm2406181. eCollection 2023 Jun.
7
Management of Cardiovascular Diseases in Chronic Hemodialysis Patients.慢性血液透析患者心血管疾病的管理
Rev Cardiovasc Med. 2023 Jun 29;24(7):185. doi: 10.31083/j.rcm2407185. eCollection 2023 Jul.
8
Semaglutide and Patients Receiving Hemodialysis: Case Reports of Unexpected Benefits for Hyperphosphatemia and Hyperkalemia.司美格鲁肽与接受血液透析的患者:高磷血症和高钾血症意外获益的病例报告
Can J Hosp Pharm. 2024 May 8;77(2):e3534. doi: 10.4212/cjhp.3534. eCollection 2024.
9
The Impact of Potassium Dynamics on Cardiomyocyte Beating in Hemodialysis Treatment.钾动力学对血液透析治疗中心肌细胞搏动的影响。
J Clin Med. 2024 Apr 15;13(8):2289. doi: 10.3390/jcm13082289.
10
Personalizing electrolytes in the dialysis prescription: what, why and how?在透析处方中个性化定制电解质:是什么、为什么以及如何做?
Clin Kidney J. 2023 Oct 13;17(1):sfad210. doi: 10.1093/ckj/sfad210. eCollection 2024 Jan.

本文引用的文献

1
Facility-level interpatient hemoglobin variability in hemodialysis centers participating in the Dialysis Outcomes and Practice Patterns Study (DOPPS): Associations with mortality, patient characteristics, and facility practices.参与 Dialysis Outcomes and Practice Patterns Study(DOPPS)的血液透析中心的患者间血红蛋白变异性与死亡率、患者特征和中心实践的关系:设施水平。
Am J Kidney Dis. 2011 Feb;57(2):266-75. doi: 10.1053/j.ajkd.2010.11.003.
2
Prevention of sudden cardiac arrest in dialysis patients: can we do more to improve outcomes?预防透析患者心搏骤停:我们能否做更多来改善预后?
Kidney Int. 2011 Jan;79(2):147-9. doi: 10.1038/ki.2010.433.
3
In-center hemodialysis six times per week versus three times per week.每周中心血液透析 6 次与每周 3 次的比较。
N Engl J Med. 2010 Dec 9;363(24):2287-300. doi: 10.1056/NEJMoa1001593. Epub 2010 Nov 20.
4
Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics.与血液透析中心内心搏骤停相关的可修正风险因素。
Kidney Int. 2011 Jan;79(2):218-27. doi: 10.1038/ki.2010.315. Epub 2010 Sep 1.
5
Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients.维生素 D 缺乏与血液透析患者的心脏性猝死、心血管综合事件和死亡率相关。
Eur Heart J. 2010 Sep;31(18):2253-61. doi: 10.1093/eurheartj/ehq246. Epub 2010 Aug 5.
6
Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective?离子交换树脂治疗高钾血症:安全有效吗?
J Am Soc Nephrol. 2010 May;21(5):733-5. doi: 10.1681/ASN.2010010079. Epub 2010 Feb 18.
7
Dialysate potassium and risk of death in chronic hemodialysis patients.透析液钾与慢性血液透析患者的死亡风险。
J Nephrol. 2010 Jan-Feb;23(1):33-40.
8
Glycemic control and cardiovascular events in diabetic hemodialysis patients.糖尿病血液透析患者的血糖控制与心血管事件。
Circulation. 2009 Dec 15;120(24):2421-8. doi: 10.1161/CIRCULATIONAHA.109.857268.
9
Changes in adiponectin and the risk of sudden death, stroke, myocardial infarction, and mortality in hemodialysis patients.脂联素变化与血液透析患者猝死、中风、心肌梗死及死亡风险
Kidney Int. 2009 Sep;76(5):567-75. doi: 10.1038/ki.2009.200. Epub 2009 Jun 10.
10
Prescription of antihypertensive agents to haemodialysis patients: time trends and associations with patient characteristics, country and survival in the DOPPS.血液透析患者抗高血压药物的处方:DOPPS研究中的时间趋势及其与患者特征、国家和生存率的关联
Nephrol Dial Transplant. 2009 Sep;24(9):2809-16. doi: 10.1093/ndt/gfp212. Epub 2009 May 14.

可改变的实践与血液透析患者在透析结果和实践模式研究中的突然死亡相关。

Modifiable practices associated with sudden death among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study.

机构信息

Department of Nephrology, Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Brussels, Belgium.

出版信息

Clin J Am Soc Nephrol. 2012 May;7(5):765-74. doi: 10.2215/CJN.08850811. Epub 2012 Mar 8.

DOI:10.2215/CJN.08850811
PMID:22403271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3338277/
Abstract

BACKGROUND AND OBJECTIVES

Sudden death is common in hemodialysis patients, but whether modifiable practices affect the risk of sudden death remains unclear.

DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This study analyzed 37,765 participants in 12 countries in the Dialysis Outcomes and Practice Patterns Study to explore the association of the following practices with sudden death (due to cardiac arrhythmia, cardiac arrest, and/or hyperkalemia): treatment time [TT] <210 minutes, Kt/V <1.2, ultrafiltration volume >5.7% of postdialysis weight, low dialysate potassium [K(D) <3]), and prescription of Q wave/T wave interval-prolonging drugs. Cox regression was used to estimate effects on mortality, adjusting for potential confounders. An instrumental variable approach was used to further control for unmeasured patient-level confounding.

RESULTS

There were 9046 deaths, 26% of which were sudden (crude mortality rate, 15.3/100 patient-years; median follow-up, 1.59 years). Associations with sudden death included hazard ratios of 1.13 for short TT, 1.15 for large ultrafiltration volume, and 1.10 for low Kt/V. Compared with K(D) ≥3 mEq/L, the sudden death rate was higher for K(D) ≤1.5 and K(D)=2-2.5 mEq/L. The instrumental variable approach yielded generally consistent findings. The sudden death rate was elevated for patients taking amiodarone, but not other Q wave/T wave interval-prolonging drugs.

CONCLUSIONS

This study identified modifiable dialysis practices associated with higher risk of sudden death, including short TT, large ultrafiltration volume, and low K(D). Because K(D) <3 mEq/L is common and easy to change, K(D) tailoring may prevent some sudden deaths. This hypothesis merits testing in clinical trials.

摘要

背景和目的

在血液透析患者中,猝死较为常见,但可改变的做法是否会影响猝死风险尚不清楚。

设计、地点、参与者和测量:本研究分析了来自 12 个国家的 37765 名参与者的 Dialysis Outcomes and Practice Patterns Study 数据,以探讨以下做法与猝死(由心律失常、心脏骤停和/或高钾血症引起)之间的关联:治疗时间(TT)<210 分钟,Kt/V <1.2,超滤量>透析后体重的 5.7%,透析液钾浓度低[K(D) <3],以及开处方使用 Q 波/T 波间期延长药物。使用 Cox 回归来估计对死亡率的影响,调整潜在混杂因素。使用工具变量法进一步控制未测量的患者水平混杂因素。

结果

共有 9046 人死亡,其中 26%为猝死(粗死亡率为 15.3/100 患者年;中位随访时间为 1.59 年)。与猝死相关的危险比包括 TT 较短为 1.13,超滤量较大为 1.15,Kt/V 较低为 1.10。与 K(D)≥3 mEq/L 相比,K(D)≤1.5 mEq/L 和 K(D)=2-2.5 mEq/L 的猝死率更高。工具变量法得出的结果大致一致。服用胺碘酮的患者猝死率升高,但服用其他 Q 波/T 波间期延长药物的患者猝死率没有升高。

结论

本研究确定了与较高猝死风险相关的可改变的透析做法,包括 TT 较短、超滤量较大和 K(D)较低。由于 K(D) <3 mEq/L 很常见且易于改变,因此调整 K(D)可能会预防一些猝死。这一假设值得在临床试验中进行检验。